Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
335.19B
Market cap335.19B
Price-Earnings ratio
106.24
Price-Earnings ratio106.24
Dividend yield
2.53%
Dividend yield2.53%
Average volume
8.73M
Average volume8.73M
High today
$135.97
High today$135.97
Low today
$133.40
Low today$133.40
Open price
$134.43
Open price$134.43
Volume
6.32M
Volume6.32M
52 Week high
$135.97
52 Week high$135.97
52 Week low
$77.58
52 Week low$77.58

Stock Snapshot

Merck(MRK) stock is priced at $135.84, giving the company a market capitalization of 335.19B. It carries a P/E multiple of 106.24 and pays a dividend yield of 2.53%.

During the trading session on 2026-08-14, Merck(MRK) shares reached a daily high of $135.97 and a low of $133.40. At a current price of $135.84, the stock is +1.8% higher than the low and still -0.1% under the high.

Trading activity shows a volume of 6.32M, compared to an average daily volume of 8.73M.

The stock's 52-week range extends from a low of $77.58 to a high of $135.97.

The stock's 52-week range extends from a low of $77.58 to a high of $135.97.

MRK News

Simply Wall St 3h
Merck Could Be 1% Undervalued On Raised Guidance And KEYTRUDA News

Merck (MRK) is back in focus after a busy early August, as Q2 results, a guidance update, fresh product approvals and new regulatory milestones for ENFLONSIA an...

Merck Could Be 1% Undervalued On Raised Guidance And KEYTRUDA News
TipRanks 18h
Massive Insider Moves Rock Merck’s Executive Suite

New insider activity at Merck & Company ( (MRK) ) has taken place on August 13, 2026. Merck & Company recently saw significant insider activity, as two top exe...

Simply Wall St 1d
Will Higher 2026 Guidance and New Approvals Shift Merck's KEYTRUDA-Heavy Narrative?

In early August 2026, Merck reported higher second-quarter sales and slightly raised its 2026 revenue guidance, while also highlighting new approvals and pipeli...

Will Higher 2026 Guidance and New Approvals Shift Merck's KEYTRUDA-Heavy Narrative?

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
25.8%
Sell
6.5%

More MRK News

TipRanks 2d
Top Merck Executive Makes Major Move With High-Value Stock Sale

New insider activity at Merck & Company ( (MRK) ) has taken place on August 12, 2026. Richard Deluca, EVP & President of Merck Animal Health, has recently sold...

24/7 Wall St. 2d
Why Revolution Medicines May Be Big Pharma's Next Takeover Target

Why Revolution Medicines May Be Big Pharma’s Next Takeover Target By Trey Thoelcke Published Aug 12, 8:50AM EDT Quick Read RVMD has surged 492% over one year...

Why Revolution Medicines May Be Big Pharma's Next Takeover Target
Simply Wall St 2d
Why Is Merck Seeking Broader RSV Use For ENFLONSIA In Children?

Merck (NYSE:MRK) reported that its RSV antibody ENFLONSIA has received filing acceptance from both the U.S. FDA and the European Medicines Agency for expanded p...

Why Is Merck Seeking Broader RSV Use For ENFLONSIA In Children?
Nasdaq 3d
Merck Q2 2026 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Merck Q2 2026 Earnings Call Transcript
Nasdaq 3d
November 20th Options Now Available For Merck

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the November 20th expiration. One of the key data points that goes into th...

November 20th Options Now Available For Merck
TipRanks 4d
Merck discloses 1.21M share holding in Evaxion Biotech

In a regulatory filing after the close on Friday, Merck (MRK) disclosed that it holds 1,214,126 shares of Evaxion Biotech (EVAX). Evaxion shares are up 7c, or 2...

TipRanks 6d
Coinbase, GM, Delta, Merck, Applied Digital: Insider Shock

Insiders have been trading these 5 stocks: ((COIN)), ((GM)), ((DAL)), ((MRK)) and ((APLD)). Here is a breakdown of their recent trades and their value. Directo...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.